Literature DB >> 28961374

Recent Progress in Near Infrared Light Triggered Photodynamic Therapy.

Kerong Deng1,2, Chunxia Li3, Shanshan Huang1, Bengang Xing4, Dayong Jin5, Qingguang Zeng1, Zhiyao Hou1, Jun Lin1,2.   

Abstract

Nowadays, photodynamic therapy (PDT) is under the research spotlight as an appealing modality for various malignant tumors. Compared with conventional PDT treatment activated by ultraviolet or visible light, near infrared (NIR) light-triggered PDT possessing deeper penetration to lesion area and lower photodamage to normal tissue holds great potential for in vivo deep-seated tumor. In this review, recent research progress related to the exploration of NIR light responsive PDT nanosystems is summarized. To address current obstacles of PDT treatment and facilitate the effective utilization, several innovative strategies are developed and introduced into PDT nanosystems, including the conjugation with targeted moieties, O2 self-sufficient PDT, dual photosensitizers (PSs)-loaded PDT nanoplatform, and PDT-involved synergistic therapy. Finally, the potential challenges as well as the prospective for further development are also discussed.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  near infrared light; photodynamic therapy; photosensitizers; targeted therapy; tumor hypoxia

Mesh:

Substances:

Year:  2017        PMID: 28961374     DOI: 10.1002/smll.201702299

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  22 in total

1.  Indocyanine Green-Coated Gold Nanoclusters for Photoacoustic Imaging and Photothermal Therapy.

Authors:  Elizabeth Higbee-Dempsey; Ahmad Amirshaghaghi; Matthew J Case; Joann Miller; Theresa M Busch; Andrew Tsourkas
Journal:  Adv Ther (Weinh)       Date:  2019-07-26

Review 2.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.

Authors:  Rafael R Castillo; Daniel Lozano; Blanca González; Miguel Manzano; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Expert Opin Drug Deliv       Date:  2019-04-22       Impact factor: 6.648

Review 3.  Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance.

Authors:  Rui Li; Zhimin Chen; Zhifei Dai; Yingjie Yu
Journal:  Cancer Biol Med       Date:  2021-03-23       Impact factor: 4.248

4.  Magnetic chitosan/graphene oxide composite loaded with novel photosensitizer for enhanced photodynamic therapy.

Authors:  Xiang Qin; Hongyue Zhang; Zhiqiang Wang; Yingxue Jin
Journal:  RSC Adv       Date:  2018-03-14       Impact factor: 4.036

Review 5.  Recent Progress in the Development of Poly(lactic-co-glycolic acid)-Based Nanostructures for Cancer Imaging and Therapy.

Authors:  Ki-Taek Kim; Jae-Young Lee; Dae-Duk Kim; In-Soo Yoon; Hyun-Jong Cho
Journal:  Pharmaceutics       Date:  2019-06-14       Impact factor: 6.321

6.  X-ray induced photodynamic therapy (PDT) with a mitochondria-targeted liposome delivery system.

Authors:  Xuefan Gu; Chao Shen; Hua Li; Ewa M Goldys; Wei Deng
Journal:  J Nanobiotechnology       Date:  2020-06-10       Impact factor: 10.435

Review 7.  Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy.

Authors:  Cherie Ann Kruger; Heidi Abrahamse
Journal:  Molecules       Date:  2018-10-13       Impact factor: 4.411

Review 8.  Functional Polymer Nanocarriers for Photodynamic Therapy.

Authors:  Tuanwei Li; Lifeng Yan
Journal:  Pharmaceuticals (Basel)       Date:  2018-11-30

Review 9.  Reactive Oxygen Species and Mitochondrial Dynamics: The Yin and Yang of Mitochondrial Dysfunction and Cancer Progression.

Authors:  Jan Ježek; Katrina F Cooper; Randy Strich
Journal:  Antioxidants (Basel)       Date:  2018-01-16

10.  Dynamin-related protein 1-mediated mitochondrial fission contributes to IR-783-induced apoptosis in human breast cancer cells.

Authors:  Qin Tang; Wuyi Liu; Qian Zhang; Jingbin Huang; Changpeng Hu; Yali Liu; Qing Wang; Min Zhou; Wenjing Lai; Fangfang Sheng; Guobing Li; Rong Zhang
Journal:  J Cell Mol Med       Date:  2018-07-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.